GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » EBITDA Margin %

Bcworldpharm Co (XKRX:200780) EBITDA Margin % : 9.48% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bcworldpharm Co's EBITDA for the three months ended in Mar. 2024 was ₩1,545 Mil. Bcworldpharm Co's Revenue for the three months ended in Mar. 2024 was ₩16,303 Mil. Therefore, Bcworldpharm Co's EBITDA margin for the quarter that ended in Mar. 2024 was 9.48%.


Bcworldpharm Co EBITDA Margin % Historical Data

The historical data trend for Bcworldpharm Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bcworldpharm Co EBITDA Margin % Chart

Bcworldpharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.72 7.29 7.10 13.04 18.52

Bcworldpharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.05 24.36 15.20 16.06 9.48

Competitive Comparison of Bcworldpharm Co's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's EBITDA Margin % falls into.



Bcworldpharm Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Bcworldpharm Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=13909.662/75110.699
=18.52 %

Bcworldpharm Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=1545.48/16302.939
=9.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bcworldpharm Co  (XKRX:200780) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Bcworldpharm Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bcworldpharm Co (XKRX:200780) Business Description

Traded in Other Exchanges
N/A
Address
78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co (XKRX:200780) Headlines

No Headlines